OVIT (OncoVista Innovative Therapies) Effect of Exchange Rate Changes: $0.00 Mil (TTM As of Sep. 2015)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is OncoVista Innovative Therapies Effect of Exchange Rate Changes?

OncoVista Innovative Therapies OVIT Effect of Exchange Rate Changes is $0.00 Mil as of Sep. 2015.

OncoVista Innovative Therapies's Effect of Exchange Rate Changes for the three months ended in Sep. 2015 was $0.00 Mil.

OncoVista Innovative Therapies's Effect of Exchange Rate Changes for the trailing twelve months (TTM) ended in Sep. 2015 was $0.00 Mil.

OncoVista Innovative Therapies Effect of Exchange Rate Changes Related Terms

OncoVista Innovative Therapies Effect of Exchange Rate Changes Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Effect of Exchange Rate Changes can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Effect of Exchange Rate Changes Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Effect of Exchange Rate Changes
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.00 0.00 0.00 0.00

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Effect of Exchange Rate Changes Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OncoVista Innovative Therapies Effect of Exchange Rate Changes Calculation

Effect of Exchange Rate Changes represents the effect of exchange rate changes on cash balances held in foreign currencies.

Effect of Exchange Rate Changes for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Effect of Exchange Rate Changes of $0.00 Mil mean?
OncoVista Innovative Therapies (OVIT) has a Effect of Exchange Rate Changes of $0.00 Mil as of Sep. 2015. Effect of Exchange Rate Changes gives the cumulative effect due to foreign exchange rate fluctuations. View historical data for OncoVista Innovative Therapies.
Is OncoVista Innovative Therapies' Effect of Exchange Rate Changes too high?
OncoVista Innovative Therapies' current Effect of Exchange Rate Changes is $0.00 Mil.
How does OncoVista Innovative Therapies' Effect of Exchange Rate Changes compare to RSPI and HSTC?
OncoVista Innovative Therapies' Effect of Exchange Rate Changes of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effect of Exchange Rate Changes for a Biotechnology company?
A good Effect of Exchange Rate Changes depends on the Biotechnology industry context. However, Effect of Exchange Rate Changes should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effect of Exchange Rate Changes mean?
A high Effect of Exchange Rate Changes can signal that a stock is expensive relative to its fundamentals. Effect of Exchange Rate Changes gives the cumulative effect due to foreign exchange rate fluctuations. View historical data for OncoVista Innovative Therapies. OncoVista Innovative Therapies's current Effect of Exchange Rate Changes is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Effect of Exchange Rate Changes of $0.00 Mil. The current Effect of Exchange Rate Changes is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effect of Exchange Rate Changes calculated?
Effect of Exchange Rate Changes is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Effect of Exchange Rate Changes is $0.00 Mil as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.